Previous 10 | Next 10 |
home / stock / rvvtf / rvvtf news
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- REVIVE THERAPEUTICS LTD. ( CSE: RVV; OTCQB: RVVTF ) (“ Revive ” or the ...
2024-01-25 04:10:08 ET More on Revive Therapeutics Financial information for Revive Therapeutics Read the full article on Seeking Alpha For further details see: Revive Therapeutics announces offering of up to $3 million
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- REVIVE THERAPEUTICS LTD. ( CSE: RVV; OTCQB: RVVTF ) (“ Revive ” or the ...
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, t...
TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is...
Bexil Corp (BXLC) is expected to report for quarter end 2023-09-30 Daily Journal Corp. (S.C.) (DJCO) is expected to report for quarter end 2023-09-30 Arch Therapeutics Inc (ARTH) is expected to report $-0.13 for Q4 2023 First Republic Bank (San Francisco, California) (FRCB) is expecte...
TORONTO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“ Revive ” or the “ Company ”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare d...
TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is...
Industrial & Commercial Bank of China Ltd. ADR (IDCBY) is expected to report for Q3 2023 Air China Ltd ADR - Level I (AIRYY) is expected to report for Q3 2023 Bexil Corp (BXLC) is expected to report for quarter end 2023-09-30 Timberline Resources Corp. (TLRS) is expected to report...
First Republic Bank (San Francisco, California) (FRCB) is expected to report for Q3 2023 GEA Group AG (GEAGF) is expected to report for Q3 2023 Janel Corp (JANL) is expected to report for quarter end 2023-09-30 Screen Holdings Co. Ltd. (DINRF) is expected to report for Q2 2024 Tom...
News, Short Squeeze, Breakout and More Instantly...
Revive Therapeutics Ltd. Company Name:
RVVTF Stock Symbol:
OTCMKTS Market:
TORONTO, April 23, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases...
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious disease...
TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, a...